#United States #New York #Class Action #The Gross Law Firm #Telix Pharmaceuticals

Telix Pharmaceuticals Class Action Notice

Attention: Shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX)
The Gross Law Firm has officially notified the investors of Telix Pharmaceuticals regarding a pending class action lawsuit. This notice is crucial for shareholders who may have experienced financial losses as a result of misleading statements made by the company.

Background Information

The class action pertains to shareholders who purchased shares of Telix Pharmaceuticals between February 21, 2025, and August 28, 2025. During this period, the company allegedly issued materially false and misleading information concerning its business operations and the quality of its products and partnerships, specifically regarding prostate cancer therapeutic candidates. These statements led to a significant misrepresentation of the company's true standing in the market.

Allegations Against Telix Pharmaceuticals

The allegations consist of three major points:
1. Overstated Progress: The complaint asserts that Telix overstated the advancements made in its prostate cancer treatments, which may have misled investors about the viability and potential profitability of these candidates.
2. Inflated Supply Chain Claims: The quality and reliability of Telix's supply chain and partnerships were allegedly exaggerated, which could have affected the company's performance and stock valuation.
3. Misleading Statements: Overall, the assertions made by Telix regarding its operations lacked any reasonable basis, resulting in materially misleading information being communicated to investors.

Important Deadlines

As a potential shareholder impacted by these events, it's vital that you respond promptly to the registration notice. The deadline to register and be effective in seeking a lead plaintiff designation is January 9, 2026. It's important to note that registering for this class action does not require you to become a lead plaintiff; participation in the recovery process is available to all registered shareholders.

Next Steps for Investors

Interested shareholders are encouraged to register their claims through the provided registration link. Following registration, you will gain access to portfolio monitoring software providing updates throughout the case lifecycle, keeping you informed about any developments related to the class action.

Why Choose The Gross Law Firm?

The Gross Law Firm possesses a solid reputation as a nationally recognized class action law firm committed to advocating for investors' rights. Their dedication focuses on protecting investors who have suffered financial losses due to deceitful and unethical corporate practices. They work diligently to hold corporations accountable for misleading statements that artificially inflate stock prices, thus ensuring responsible business conduct across the market.

For further inquiries, shareholders can reach The Gross Law Firm directly at their New York office:
Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Don't miss out on the chance to protect your investment. Register today and take the first step towards reclaiming your losses.